A new international advanced training course dedicated to sarcomas is born from the collaboration between the European School of Oncology (ESO) andUniversità Campus Bio-Medico di Roma (UCBM). And the Master's Degree in Sarcoma, an academic program that brings together specialists from some of the leading European oncology centers and professionals from around the world, with the aim of deepening the most advanced diagnostic and therapeutic strategies for the management of these rare and complex tumors.
This international dimension is visible from the very beginning of the Master, September 25th atUniversità Campus Bio-Medico di RomaWith the participation of 27 doctors from 20 countriesAlongside the Italian professionals, colleagues from France, Germany, Romania, and Ukraine will be present, as well as from Brazil, Mexico, Argentina, Uruguay, Algeria, Iraq, and Jordan.
Medical oncologists, surgeons, radiation oncologists, radiologists, and pathologists They discuss the decisions that accompany sarcoma care: from diagnosis to treatment selection and sequencing. The program includes soft tissue and bone sarcomas, desmoid tumors, pediatric and uterine sarcomas, and gastrointestinal stromal tumors, or GISTs.
Leading the course is Bruno Vincenzi, Host Chair, medical oncologist at the Fondazione Policlinico Universitario Campus Bio-Medico and Dean of the Faculty of Medicine, Surgery and Dentistry at theUniversità Campus Bio-Medico di RomaHis clinical and research activity focuses on rare tumors, with particular attention to soft tissue sarcomas and GISTs.
Multidisciplinarity is the cornerstone of the diagnosis and treatment of sarcomas, an extremely heterogeneous group of rare tumors that affect connective tissues such as muscle, bone, fat, and blood vessels. Due to their complexity and the variety of histological subtypes (over 80-100 variants), no single medical specialty can manage them in isolation. The correct approach requires constant interaction within a Sarcoma Board (or Multidisciplinary Oncology Group - GOM) composed of oncological/orthopedic surgeons, medical oncologists, radiation oncologists, expert pathologists, and radiologists. To meet this training need and consolidate an approach, we have chosen to create a high-level academic training program like this Master's degree. The aim is to provide professionals with advanced skills and concrete tools to address the complexity of patient care and contribute, through qualified and multidisciplinary training, to the evolution of clinical practice." has ofchiarato the Prof. Bruno Vincenzi.
The scientific direction is also entrusted to Sylvie Bonvalot, Chair of the course, surgical oncologist and head of the Sarcoma Unit at the Institut Curie in Paris. Representing ESO College will be Silvia Brotea-Mosoiu, a medical oncologist at the Oncology Institute of Bucharest. The course begins with the World Health Organization classification and molecular biology, then delves into imaging, biopsy techniques, and anatomical-radiological correlations. Subsequent sessions focus on quality criteria in sarcoma surgery, systemic treatments, and the role, sequencing, and fractionation of radiotherapy in localized and metastatic disease.
Particular attention is paid to treatment selection based on the histological subtype and the clinical and molecular characteristics of the tumor. In addition to lectures, the program includes the presentation and multidisciplinary discussion of clinical cases prepared by the faculty and the participants themselves.
The course involves specialists from some of Europe's leading oncology centers. Speakers include: Angelo Paolo Dei Tos (University of Padua), Armelle Dufresne (Centre Léon Bérard in Lyon), Dario Callegaro e Carlo Morosi (IRCCS Foundation National Cancer Institute of Milan), Nathalie Gaspar and Carine Ngo (Gustave Roussy), Sarah Watson e Sylvie Bonvalot (Curie Institute).
They will also participate Piotr Rutkowski e Mateusz Spalek (Maria Skłodowska-Curie National Research Institute of Oncology in Warsaw), Sebastian Bauer (University Hospital Essen – West German Cancer Center), Rick Haas (Netherlands Cancer Institute), Renato Covello (Regina Elena National Cancer Institute of Rome), Salvatore Gitto (IRCCS Galeazzi-Sant'Ambrogio Hospital of Milan), Salvatore Provenzano e Paolo Giovanni Estate (IRCCS Foundation National Cancer Institute of Milan).
The new Master's Degree in Sarcoma is the academic path developed by the European School of Oncology in collaboration with theUniversità Campus Bio-Medico di Roma to strengthen the clinical and scientific skills of professionals involved in the treatment of sarcomas.
The Master will last for 15 months and will integrate theoretical training and field experience. The program includes ten online modules, two in-person seminars, a clinical internship at a unit specialized in sarcoma care and the preparation and discussion of a final thesis.
The complete program and the list of faculty are available on the website European School of Oncology.
